DailyStocks Stock Article Search

https://www.zacks.com/stock/news/2257229/merck-mrk-advances-while-market-declines-some-information-for-investors?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v1-2257229 Apr 17, 2024 - In the most recent trading session, Merck (MRK) closed at $125.37, indicating a +0.25% shift from the previous trading day. 0

https://www.fool.com/earnings/call-transcripts/2024/04/25/merck-mrk-q1-2024-earnings-call-transcript/?source=iedfolrf0000001 Apr 25, 2024 - MRK earnings call for the period ending March 31, 2024. 0

https://www.zacks.com/stock/news/2262673/astrazeneca-azn-q1-earnings-sales-beat-estimates-stock-up?cid=CS-ZC-FT-analyst_blog|earnings_article-2262673 Apr 25, 2024 - AstraZeneca (AZN) beats first-quarter estimates for earnings and sales, driven by increased demand for its key oncology and rare disease drugs. 0

https://www.zacks.com/stock/news/2217328/gsk-gears-up-for-q4-earnings-will-it-surpass-estimates?cid=CS-ZC-FT-analyst_blog|earnings_preview-2217328 Jan 29, 2024 - We expect GSK's specialty products like Arexvy, Cabenuva, Dovato, Bexsero, Trelegy Ellipta and Shingrix to drive fourth-quarter sales performance. 0

https://www.zacks.com/stock/news/2217012/countdown-to-merck-mrk-q4-earnings-wall-street-forecasts-for-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm_preview-2217012 Jan 29, 2024 - Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Merck (MRK), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended December 2023. 0

https://www.zacks.com/stock/news/2219647/merck-mrk-q4-earnings-taking-a-look-at-key-metrics-versus-estimates?cid=CS-ZC-FT-fundamental_analysis|nfm-2219647 Feb 01, 2024 - The headline numbers for Merck (MRK) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals. 0

https://www.fool.com/earnings/call-transcripts/2024/02/01/merck-mrk-q4-2023-earnings-call-transcript/?source=iedfolrf0000001 Feb 01, 2024 - MRK earnings call for the period ending December 31, 2023. 0

https://www.zacks.com/stock/news/2220267/stock-market-news-for-feb-2-2024?cid=CS-ZC-FT-market_news-2220267 Feb 02, 2024 - U.S. stocks closed higher on Thursday as they tried to recover from a massive selloff in the previous session after the Federal Reserve held interest rates steady but also said that a rate cut in March is unlikely. 0

https://www.zacks.com/stock/news/2221915/merck-mrk-unit-to-buy-elanco-s-aqua-business-for-1-3b?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2221915 Feb 06, 2024 - Merck's (MRK) Animal Health unit is set to strengthen its position with the acquisition of Elanco Animal Health's aqua business for $1.3 billion. The transaction is expected to close by mid-2024. 0

https://www.fool.com/investing/2024/02/08/heres-why-merck-eli-lilly-and-novo-nordisk-stocks/?source=iedfolrf0000001 Feb 08, 2024 - Investors are still excited about obesity treatments and weight-management drugs. 0